Ultrasound‐guided manual vacuum aspiration (USG‐MVA) is an effective but underutilised alternative to medical or surgical evacuation of the uterus following first trimester miscarriage.

To evaluate the efficacy, feasibility and patient acceptability of USG‐MVA for treating early pregnancy loss.

Material and Methods
We invited patients with early pregnancy losses to participate in this prospective cohort study. We reviewed the medical records of the participants and their visual analogue pain score during MVA. Primary outcomes were efficacy, feasibility and patient acceptability of USG‐MVA. Secondary outcomes included the success rate of culture of chorionic villi for chromosomal analysis and complications from the USG‐MVA procedure.

We included a consecutive series of 35 women who underwent the USG‐MVA procedure. The efficacy of USG‐MVA in achieving complete evacuation was 97.1%. The procedure was well tolerated and the mean procedure‐related pain score was 6.25 out of 10 (SD 1.55). Overall, all patients were satisfied with the procedure. The successful culture rate of chromosomal analysis was 94.3%. There were no major complications.

USG‐MVA is an effective treatment for the management of early pregnancy loss in an out‐patient setting. It is an alternative to surgical evacuation under general anaesthesia, particularly for women desiring chromosomal analysis of products of conception. Further studies are required to investigate its health‐related and economic benefits in hospital service provision.